Table 1.

Presentations given at the 2010 Molecular Surgeon Symposium on Personalized Genomic Medicine and Surgery (PGMS)

Speaker	Presentation topic
F. Charles Brunicardi, MD, FACS	PDX-1 as an archetype for PGMS
Richard Gibbs, PhD	Genomics in personalized medicine
John Nemunaitis, MD	Personalized therapeutics using gene based technology
Gustavo Ayala, MD	From nerves to gene regulation
David Wheeler, PhD	Mutation profiling in human cancer using second generation sequencers
William E. Fisher, MD, FACS,	Can genomic studies overcome the universal failure of clinical trials in pancreatic cancer?
Kenneth L. Scott, PhD	Oncogenomics-guided functional screening for metastasis determinants
Qizhi (Cathy) Yao, MD, PhD	Trop2: expression, DNA sequence and functions in pancreatic cancer
Christian Marin-Muller	Mesothelin and miR-198: Expression, DNA sequence and functions in pancreatic cancer
Sarah M. Weakley, MD	Loss of XIST enhances the tumor growth and pathogenesis of female human pancreatic cancer
Changyi (Johnny) Chen, MD, PhD	miR-196a: Expression, DNA sequence and functions in pancreatic cancer
Min Li, PhD	ZIP4 is a novel therapeutic target in pancreatic cancer
Guisheng Zhou, PhD	SSTR5 P335L acts as a hypofunctional single-nucleotide polymorphism (SNP) by upregulating PDX-1 expression
Amy L. McGuire, PhD, JD	Genome research, biobanking, and shared resources
Courtney J. Balentine, MD	Flipping the cancer master switch
Dolores J. Lamb, PhD	Identification of de novo copy number variants associated with human disorders of genitourinary development
Jacfranz Guiteau, MD	Development and maintenance of an HCC bioresource bank: practical issues
Ronald T. Cotton, MD	Liver cancer genome: Mutation profiling for viral hepatitis-associated hepatocellular carcinoma
Seth P. Lerner, MD	p53 targeted therapy trial for organ confined invasive urothelial bladder cancer